This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Johansson, B. B. Search for Related Content PubMed PubMed Citation Articles by Johansson, B. B.

Stroke, Vol 17, 744-747, Copyright © 1986 by American Heart Association

ARTICLES

Pentoxifylline: cerebral blood flow and glucose utilization in conscious spontaneously hypertensive rats

BB Johansson

Pentoxifylline, 0.30 mg/kg/min, significantly reduced cerebral blood flow by 10-44% in 19 of 23 regions studied in conscious spontaneously hypertensive rats. Bilateral ligation of the common carotid arteries reduced cerebral blood flow to 24-46% of resting values in 20 structures; a further reduction to 10-27% of resting values was seen after pentoxifylline in 10 cortical or subcortical structures. Thus, in conscious hypertensive rats, there is no evidence that pentoxifylline redistributes blood flow from normal to low flow brain regions. Pentoxifylline did not reduce the metabolic rate of glucose.